Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and other GLP-1 receptor agonists have transformed weight management, but patients planning pregnancy or currently pregnant often face critical questions about safety. Current clinical evidence suggests GLP-1 medications should be discontinued before conception and throughout pregnancy, though individual circumstances vary based on metabolic health and medical history.
How Semaglutide Affects Fertility and Conception
Semaglutide works by activating GLP-1 receptors in the brain and pancreas, slowing stomach emptying and increasing feelings of fullness. These same receptors exist in reproductive tissues, which means GLP-1 compounds may influence ovulation timing, sperm production, and hormone signaling involved in conception. Most fertility specialists recommend discontinuing semaglutide at least 2-3 months before attempting pregnancy to allow metabolic normalization and hormone cycles to stabilize.
Weight loss itself can restore fertility in individuals with obesity-related infertility by improving insulin sensitivity and reducing excess androgens that disrupt ovulation. However, the rapid weight loss from GLP-1 therapy during the conception window may stress reproductive hormone balance temporarily. PlexusDx recommends consulting both your weight loss provider and fertility specialist if pregnancy planning is on your timeline, ensuring coordinated care across both specialties.
Semaglutide Safety During Pregnancy: Current Evidence
No large randomized controlled trials have evaluated semaglutide safety in pregnant humans, which is why regulatory guidance and clinical practice universally recommend stopping GLP-1 medications immediately upon positive pregnancy test or before conception attempts. Animal studies have shown mixed results—some animal models indicate potential fetal risk at high doses, though others show no clear teratogenic effects at therapeutic doses.
The precautionary approach exists because pregnancy involves critical windows of organ development where any medication exposure carries theoretical risk. Gestational diabetes and metabolic dysfunction during pregnancy are serious concerns that warrant proactive management, but that management typically involves insulin, lifestyle modifications, and close glucose monitoring rather than GLP-1 compounds. Your obstetric team can recommend pregnancy-safe approaches to metabolic health if gestational diabetes develops.
When to Stop Semaglutide if Planning Pregnancy
Medical guidelines suggest discontinuing semaglutide 2-3 months before attempting pregnancy. This timeframe allows the medication to clear your system completely, permits hormonal cycles to normalize, and ensures your body has returned to baseline metabolic function. If you become pregnant unexpectedly while on semaglutide, contact your healthcare provider immediately—stopping the medication at that point is standard practice, and no single dose exposure carries known severe fetal risk.
During the off-treatment months, focus on maintaining weight loss through nutrition and movement, as rapid weight regain may complicate conception or early pregnancy. Some patients work with a registered dietitian to transition from medication-supported weight management to sustainable lifestyle patterns. PlexusDx providers can help coordinate this transition and discuss when resuming compounded semaglutide might be appropriate after pregnancy and breastfeeding (typically 6-12 months postpartum, depending on individual factors).
Personalized GLP-1 Therapy and Reproductive Planning
PlexusDx offers compounded semaglutide injection starting at $149 per month from licensed 503A compounding pharmacies, making personalized weight loss therapy accessible without insurance. If you're planning pregnancy, your PlexusDx provider can review your treatment timeline, adjust tapering schedules, and ensure continuity of care with your OB/GYN. The Precision Peptide Genetic Test ($99 add-on after first month) maps your genetic predispositions across 14 metabolic pathways, revealing whether your body responds differently to GLP-1 signaling—information that may inform post-pregnancy treatment optimization.
Weight management before conception improves pregnancy outcomes significantly, reducing risks of gestational diabetes, preeclampsia, and fetal complications. Starting compounded semaglutide well before pregnancy attempts allows time to achieve meaningful weight loss while you're still able to use the medication safely. After delivery and breastfeeding completion, resuming GLP-1 therapy can help sustain the metabolic improvements you gained, preventing postpartum weight regain.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take semaglutide while trying to get pregnant?
Most fertility and reproductive endocrinology specialists recommend stopping semaglutide 2-3 months before attempting conception. This allows your hormones to normalize and your body to stabilize metabolically. If you're planning pregnancy, discuss timing with both your weight loss provider and fertility specialist to ensure coordinated care.
Can semaglutide cause birth defects if taken during early pregnancy?
No human studies have established birth defects from semaglutide exposure, but animal data is mixed and insufficient to guarantee safety. For this reason, medical guidance universally recommends discontinuing GLP-1 compounds before pregnancy and throughout gestation.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month and is available in all 50 states without insurance or membership fees. HSA and FSA accounts are eligible for payment, making it accessible alongside other family planning expenses.
Does GLP-1 therapy help with fertility, or does it hurt it?
Weight loss from GLP-1 therapy can restore fertility by improving insulin sensitivity and hormone balance in individuals with obesity-related infertility. However, the medications themselves should be paused during the conception window because their effects on GLP-1 receptors in reproductive tissues are not fully understood in humans.
Can the Precision Peptide Genetic Test help me plan pregnancy around GLP-1 therapy?
The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 14 metabolic pathways, revealing how efficiently your body responds to GLP-1 signaling.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Help Fibromyalgia? Research and Findings
Managing Constipation on GLP-1 Medications: Can You Take a Laxative with Ozempic and Similar Drugs?